One Shot… Two Shots…New Shots… Injectable COVID-19 Therapeutic Options – 2 CE
Pharmacist Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:
- Discuss the various COVID-19 vaccines authorized for use in the United States
- Summarize the evidence of remdesivir in the treatment of COVID-19
- Describe the utility for IL-6 inhibitors for treatment of COVID-19
- Select patients most beneficial of monoclonal antibodies with COVID-19
AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-848439.
Shyam Gelot, PharmD, BCPS, earned his PharmD from the University of North Carolina Eshelman School of Pharmacy and completed a PGY1 pharmacy practice residency at Tampa General Hospital in Florida. He has nearly 14 years of experience in clinical services, teaching, research, management, and pharmacy distribution in academia, community pharmacy and hospital practice. He has no actual or potential conflicts of interest to disclose.
Financial Support Disclosure
This activity was developed by AchieveCE free of any commercial support. Shyam Gelot, PharmD, BCPS has no actual or potential conflicts of interest to disclose.
Level 2. Basic Application of Skills and Concepts
Home Study Monograph
2.0 Contact Hours
Universal Activity Number
Activity Release Date
August 12, 2021
Activity Expiration Date
August 12, 2024
Handout Download Link(s)
Requirements for Credit
Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+
Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
Ready to Start?
You may also be interested in: